The effect of resveratrol in combination with irradiation and chemotherapy: study using Merkel cell carcinoma cell lines.
Strahlenther Onkol
; 190(1): 75-80, 2014 Jan.
Article
em En
| MEDLINE
| ID: mdl-24196280
ABSTRACT
BACKGROUND AND PURPOSE:
Merkel cell carcinoma (MCC) is a rare, but highly malignant tumor of the skin. In case of systemic disease, possible therapeutic options include irradiation or chemotherapy. The aim of this study was to evaluate whether the flavonoid resveratrol enhances the effect of radiotherapy or chemotherapy in MCC cell lines. MATERIALS ANDMETHODS:
The two MCC cell lines MCC13 and MCC26 were treated with increasing doses of resveratrol. Combination experiments were conducted with cisplatin and etoposide. Colony forming assays were performed after sequential irradiation with 1, 2, 3, 4, 6, and 8 Gy and apoptosis was assessed with flow cytometry. Expression of cancer drug targets was analyzed by real-time PCR array.RESULTS:
Resveratrol is cytotoxic in MCC cell lines. Cell growth is inhibited by induction of apoptosis. The combination with cisplatin and etoposide resulted in a partially synergistic inhibition of cell proliferation. Resveratrol and irradiation led to a synergistic reduction in colony formation compared to irradiation alone. Evaluation of gene expression did not show significant difference between the cell lines.CONCLUSION:
Due to its radiosensitizing effect, resveratrol seems to be a promising agent in combination with radiation therapy. The amount of chemosensitizing depends on the cell lines tested.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Estilbenos
/
Carcinoma de Célula de Merkel
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Quimiorradioterapia
Limite:
Humans
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article